https://ir.canfite.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/canfite/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.canfite.com/news-events/press-releases/detail/1130/can-fite-to-pursue-global-licensing-and-strategic Fri, 06 Nov 26 07:23:00 -0500 https://ir.canfite.com/news-events/press-releases/detail/1130/can-fite-to-pursue-global-licensing-and-strategic https://ir.canfite.com/news-events/press-releases/detail/1129/can-fite-announces-eurasian-patent-allowance-supporting Mon, 02 Nov 26 07:00:00 -0500 https://ir.canfite.com/news-events/press-releases/detail/1129/can-fite-announces-eurasian-patent-allowance-supporting https://ir.canfite.com/news-events/press-releases/detail/1128/can-fite-presents-final-positive-data-from-phase-iia Mon, 26 Oct 26 07:00:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1128/can-fite-presents-final-positive-data-from-phase-iia https://ir.canfite.com/news-events/press-releases/detail/1127/can-fite-publication-reports-improvement-in-decompensated Wed, 09 Sep 26 07:00:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1127/can-fite-publication-reports-improvement-in-decompensated https://ir.canfite.com/news-events/press-releases/detail/1126/can-fite-reports-q2-2026-financial-results-and-ongoing Tue, 08 Sep 26 08:20:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1126/can-fite-reports-q2-2026-financial-results-and-ongoing https://ir.canfite.com/news-events/press-releases/detail/1125/can-fite-announces-exercise-of-warrants-for-approximately Wed, 02 Sep 26 09:02:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1125/can-fite-announces-exercise-of-warrants-for-approximately https://ir.canfite.com/news-events/press-releases/detail/1124/can-fite-reports-longer-than-anticipated-overall-survival Wed, 02 Sep 26 07:00:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1124/can-fite-reports-longer-than-anticipated-overall-survival https://ir.canfite.com/news-events/press-releases/detail/1123/can-fite-namodenoson-enhances-the-anti-cancer-effect-of Mon, 17 Aug 26 07:00:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1123/can-fite-namodenoson-enhances-the-anti-cancer-effect-of https://ir.canfite.com/news-events/press-releases/detail/1122/can-fite-highlights-advanced-fda-and-ema-regulatory-status Wed, 12 Aug 26 07:00:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1122/can-fite-highlights-advanced-fda-and-ema-regulatory-status https://ir.canfite.com/news-events/press-releases/detail/1121/can-fite-launches-first-clinical-program-for-piclidenoson Mon, 03 Aug 26 07:00:00 -0400 https://ir.canfite.com/news-events/press-releases/detail/1121/can-fite-launches-first-clinical-program-for-piclidenoson